{"url_path":"/sec/asmb/8-k/2026-06-05/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-05","source_url":"https://www.sec.gov/Archives/edgar/data/1426800/0001193125-26-259481-index.html","accession_number":"0001193125-26-259481","cik":"0001426800","ticker":"ASMB","issuer_name":"ASSEMBLY BIOSCIENCES, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1426800/0001193125-26-259481-index.html","primary_entity_key":"0001426800","primary_entity_name":"ASSEMBLY BIOSCIENCES, INC."},"word_count":331,"has_tables":true,"body_markdown":"Item 5.07 Submission of Matters to a Vote of Security Holders.\n\nOn June 4, 2026, the matters listed below were submitted to a vote of the Company's stockholders at the Annual Meeting through the solicitation of proxies. Detailed descriptions of each of the proposals are included in the Proxy Statement.\n\n1. The stockholders elected of the following to serve on the Company's Board of Directors until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Anthony E. Altig; Tomas Cihlar, Ph.D.; Gina Consylman; Robert D. Cook II; Sir Michael Houghton, Ph.D.; Lisa R. Johnson-Pratt, M.D.; Susan Mahony, Ph.D.; John G. McHutchison, A.O., M.D.; and Jason A. Okazaki.\n\n \n\nDirector Nominee\n\nVotes For\n\nVotes Against\n\nAbstain\n\nBroker Non-Votes\n\nAnthony E. Altig\n\n11,300,212\n\n16,008\n\n621\n\n1,069,023\n\nTomas Cihlar, Ph.D.\n\n11,300,997\n\n15,204\n\n640\n\n1,069,023\n\nGina Consylman\n\n11,311,916\n\n4,222\n\n703\n\n1,069,023\n\nRobert D. Cook II\n\n11,301,190\n\n15,185\n\n466\n\n1,069,023\n\nSir Michael Houghton, Ph.D.\n\n11,312,521\n\n3,933\n\n387\n\n1,069,023\n\nLisa R. Johnson-Pratt, M.D.\n\n11,296,644\n\n3,662\n\n16,535\n\n1,069,023\n\nSusan Mahony, Ph.D.\n\n11,311,952\n\n4,185\n\n704\n\n1,069,023\n\nJohn G. McHutchison, A.O., M.D.\n\n11,274,020\n\n15,738\n\n27,083\n\n1,069,023\n\nJason A. Okazaki\n\n11,310,730\n\n5,729\n\n382\n\n1,069,023\n\n2. The stockholders approved, on a non-binding advisory basis, the Company's named executive officers' compensation disclosed in the Proxy Statement.\n\n \n\nVotes For\n\nVotes Against\n\nAbstain\n\nBroker Non-Votes\n\n11,293,061\n\n5,401\n\n18,379\n\n1,069,023\n\n3. The stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.\n\n \n\nVotes For\n\nVotes Against\n\nAbstain\n\nBroker Non-Votes\n\n12,382,746\n\n2,943\n\n175\n\n—\n\n4. The stockholders approved Amendment No. 3 to the 2018 Plan to increase the number of shares reserved for issuance under the 2018 Plan by 1,200,000 shares.\n\n1\n\n \n\n \n\nVotes For\n\nVotes Against\n\nAbstain\n\nBroker Non-Votes\n\n11,290,805\n\n24,242\n\n1,794\n\n1,069,023\n\n5. The stockholders approved the ESPP Amendment No. 2 to increase the number of shares reserved under the ESPP to 515,000 shares.\n\n \n\nVotes For\n\nVotes Against\n\nAbstain\n\nBroker Non-Votes\n\n11,305,253\n\n9,343\n\n2,245\n\n1,069,023"}